Takeda, Mylan Drop Claims In Diabetes Drug Suit

Law360, New York (October 22, 2008, 12:00 AM EDT) -- Takeda Pharmaceutical Co. Ltd. and Mylan Inc. have agreed to dismiss claims related to one of four patents at issue in a lawsuit over Mylan's plans to develop a generic version of the diabetes drug Actoplus Met.

Judge Denise L. Cote of the U.S. District Court for the Southern District of New York on Tuesday granted a joint motion by the two companies to dismiss Mylan's counterclaims of noninfringement and invalidity of U.S. Patent Number 6,166,042, issued in 2000 and titled “Pharmaceutical composition.”

The patent was...
To view the full article, register now.